Scientists: A New Way to Control Appetite

Scientists: A New Way to Control Appetite

Scientists: A New Way to Control Appetite

According to “Daily Science”, scientists from the Scripps Research Institute in the United States recently discovered a wonderful catalytic antibody that can effectively help the body reduce appetite.

This antibody acts primarily on a gastric hormone auxin that is associated with weight gain and slight accumulation.

This discovery undoubtedly provides a new way for humans to use biomedicine to treat excessive symptoms.

  The study was funded by a researcher at the Scripps Research Institute.

Yanda and Eric.

Co-led by Zorilla, the study found that the rat’s catalytic antibody GHR-11E11 in the body after 24 hours of fasting resulted in a higher metabolic rate than usual.

Yanda said: “Our research shows that this new catalyzed antibody can effectively reduce auxin levels.

To help the body achieve the goal of successful weight loss.

According to the latest report of the World Health Organization, about 100 million people worldwide are overweight or obese, and most of them are making progress.

For example, in the United States, the Health and Nutrition Survey found that between 2006 and 2004, approximately 66 percent of adults aged 20 or older were overweight or obese to varying degrees.

According to a 2006 study published by the American Medical Association, four out of every five American men between the ages of 40 and 59 are overweight.

Although some non-surgical treatments can reduce obesity, weight gain and loss are still controlled by the body’s auxin, which stimulates the body to eat when the body is obese.

They promote weight gain and micro-storage through metabolism, reducing trace amounts of decomposition.

At weight loss, the body automatically produces more auxin to stimulate the body to eat.

Studies have shown that people always have high levels of auxin before eating and will fall after meals.

This lifting cycle of auxin will be related to blood sugar content, content and somatostatin.

Scientists have shown that mice without this auxin will not have the desire to eat during drought.

In addition, reductions in auxin receptors have been shown to reduce food intake while promoting the breakdown of adults in the body to ensure blood glucose levels.

Yanda’s research shows that this catalytic antibody can reduce the auxin content in serum to regulate energy balance.

“We chose to use this method to control obesity because other medications have failed, and the use of catalytic antibodies is the only effective way to ensure that weight does not rebound after stopping treatment.

The treatment of obesity must be achieved by reducing food intake and light consumption, which is what this new generation of catalytic antibodies can do.

Some people may worry, because auxin is produced by the body itself, and it will have side effects if it is eliminated.

According to the latest research, the human body itself also produces antibodies that eliminate auxin.

“This drug treatment for auxin has its unique advantages.

First, it does not replace the central nervous system.

In fact, it works in the blood and is relatively safer and more effective.

  Yanda said that with regard to the complexity of obesity, drug treatment based on any antibody must be combined with other drugs to achieve a comprehensive treatment including nutritional, psychological and physical diseases.

At the same time, he added that in order for this treatment to work more effectively, scientists need to have a deeper understanding of the long-term effects of catalytic antibodies and the effects of different body weights.